County of Smith v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-45081 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Jan 23, 2018 |
| Case in other court: | Texas Eastern, 6:17-cv-00699 |
| Last checked: Friday Nov 08, 2019 5:05 PM EST |
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Morris & Dickson Co., LLC
|
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
|
|
Defendant
Omnicare, Inc.
|
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical Companies, Inc.
|
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Wal-Mart Stores Texas, LLC
|
|
|
Defendant
Walgreen Co.
|
Represented By
|
|
Defendant
Walmart Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
CVS Pharmacy, Inc.
|
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Allergan Finance LLC
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
AmerisourceBergen Corporation
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Does 1-100, Inclusive
|
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Hikma Pharmaceuticals USA Inc.
|
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Plaintiff
County of Smith
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Knoll Pharmaceutical Company
Terminated: 03/23/2018
|
|
|
Defendant
AbbVie Inc.
Terminated: 03/23/2018
|
|
| Docket last updated: 04/08/2019 6:10 PM EDT |
| Tuesday, December 19, 2017 | ||
| DEMAND for Trial by Jury by County of Smith. (mll, ) [Transferred from txed on 1/23/2018.] | ||
| District Judge Robert W. Schroeder, III and Magistrate Judge John D. Love added. (rlf) [Transferred from txed on 1/23/2018.] | ||
| 1 | 1
COMPLAINT AND JURY DEMAND against All Defendants ( Filing fee $ 400 receipt number 0540-6594698.), filed by County of Smith.(Simon, Jeffrey) [Transferred from txed on 1/23/2018.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| Wednesday, December 20, 2017 | ||
| 2 | 2
NOTICE of Attorney Appearance by John F Walker on behalf of County of Smith (Walker, John) [Transferred from txed on 1/23/2018.]
|
|
| 3 | 3
NOTICE of Attorney Appearance by Reid William Martin on behalf of County of Smith (Martin, Reid) [Transferred from txed on 1/23/2018.]
|
|
| 4 | 4
NOTICE of Attorney Appearance by Amy M. Carter on behalf of County of Smith (Carter, Amy) [Transferred from txed on 1/23/2018.]
|
|
| 5 | 5
SUMMONS Issued as to All Defendants and emailed to pltf for service..(mll, ) [Transferred from txed on 1/23/2018.]
|
|
|
Att: 1
Summons(es) Actavis LLC,
|
||
|
Att: 2
Summons(es) Actavis Pharma Inc,
|
||
|
Att: 3
Summons(es) Allergan Finance,
|
||
|
Att: 4
Summons(es) AmerisourceBergen Corp,
|
||
|
Att: 5
Summons(es) Cardnial Health,
|
||
|
Att: 6
Summons(es) Endo Health Solutions,
|
||
|
Att: 7
Summons(es) Endo Pharmaceuticals,
|
||
|
Att: 8
Summons(es) Janssen Pharmaceuticals,
|
||
|
Att: 9
Summons(es) Johnson & Johnson,
|
||
|
Att: 10
Summons(es) Knoll Pharmaceutical,
|
||
|
Att: 11
Summons(es) McKesson Corp,
|
||
|
Att: 12
Summons(es) Purdue Pharma Inc,
|
||
|
Att: 13
Summons(es) Purdue Pharma LP,
|
||
|
Att: 14
Summons(es) Purdue Frederick Company,
|
||
|
Att: 15
Summons(es) Watson Laboratories
|
||
| Thursday, December 21, 2017 | ||
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form[LINK:Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge . (rlf) [Transferred from txed on 1/23/2018.] | ||
| 6 | 6
CASE REFERRED to Magistrate Judge John D. Love. (rlf) [Transferred from txed on 1/23/2018.]
|
|
| Friday, January 05, 2018 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint7 is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 2/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint8 is granted pursuant to Local Rule CV-12 for Cardinal Health, Inc. to 3/5/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| 7 | 7
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Cardinal Health, Inc..( Geyer, Christopher) [Transferred from txed on 1/23/2018.]
|
|
| 8 | 8
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Cardinal Health, Inc.(Geyer, Christopher) [Transferred from txed on 1/23/2018.]
|
|
| Wednesday, January 10, 2018 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint9 is granted pursuant to Local Rule CV-12 for Allergan Finance LLC to 2/10/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint10 is granted pursuant to Local Rule CV-12 for Allergan Finance LLC to 2/26/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint11 is granted pursuant to Local Rule CV-12 for Watson Laboratories, Inc. to 2/15/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint12 is granted pursuant to Local Rule CV-12 for Actavis LLC to 2/15/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint13 is granted pursuant to Local Rule CV-12 for Actavis Pharma, Inc. to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| 9 | 9
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 1/23/2018.]
|
|
| 10 | 10
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Allergan Finance LLC.( Hill, Jack) [Transferred from txed on 1/23/2018.]
|
|
| 11 | 11
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Watson Laboratories, Inc..( Stanfield, Craig) [Transferred from txed on 1/23/2018.]
|
|
| 12 | 12
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis LLC.( Stanfield, Craig) [Transferred from txed on 1/23/2018.]
|
|
| 13 | 13
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Actavis Pharma, Inc..( Stanfield, Craig) [Transferred from txed on 1/23/2018.]
|
|
| 14 | 14
CORPORATE DISCLOSURE STATEMENT filed by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc. identifying Corporate Parent Teva Pharmaceutical Industries Ltd for Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Stanfield, Craig) [Transferred from txed on 1/23/2018.]
|
|
| 15 | 15
CORPORATE DISCLOSURE STATEMENT filed by Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc. (Sibiski, Hannah) [Transferred from txed on 1/23/2018.]
|
|
| 16 | 16
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Health Solutions, Inc..(Sibiski, Hannah) [Transferred from txed on 1/23/2018.]
|
|
| 17 | 17
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals, Inc..(Sibiski, Hannah) [Transferred from txed on 1/23/2018.]
|
|
| Thursday, January 11, 2018 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint16 is granted pursuant to Local Rule CV-12 for Endo Health Solutions, Inc. to 2/16/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint17 is granted pursuant to Local Rule CV-12 for Endo Pharmaceuticals, Inc. to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint18 is granted pursuant to Local Rule CV-12 for McKesson Corporation to 2/17/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint19 is granted pursuant to Local Rule CV-12 for McKesson Corporation to 3/4/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint20 is granted pursuant to Local Rule CV-12 for Endo Health Solutions, Inc. to 3/5/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint21 is granted pursuant to Local Rule CV-12 for Endo Pharmaceuticals, Inc. to 2/27/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| 18 | 18
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 1/23/2018.]
|
|
| 19 | 19
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re McKesson Corporation.( Scott, Robert) [Transferred from txed on 1/23/2018.]
|
|
| 20 | 20
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Health Solutions, Inc..(Sibiski, Hannah) [Transferred from txed on 1/23/2018.]
|
|
| 21 | 21
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Endo Pharmaceuticals, Inc..(Sibiski, Hannah) [Transferred from txed on 1/23/2018.]
|
|
| 22 | 22
NOTICE of Attorney Appearance by Brett Fisher Miller on behalf of Allergan Finance LLC (Miller, Brett) [Transferred from txed on 1/23/2018.]
|
|
| 23 | 23
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| 24 | 24
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Purdue Pharma L.P.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| 25 | 25
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| 26 | 26
CORPORATE DISCLOSURE STATEMENT filed by Purdue Pharma Inc., Purdue Pharma L.P., The Purdue Frederick Company [Transferred from txed on 1/23/2018.]
|
|
| 27 | 27
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma Inc.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| 28 | 28
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re Purdue Pharma L.P.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| 29 | 29
Defendant's Unopposed Second Application for Extension of Time to Answer Complaint re The Purdue Frederick Company.( Reed, Noelle) [Transferred from txed on 1/23/2018.]
|
|
| Friday, January 12, 2018 | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint23 is granted pursuant to Local Rule CV-12 for Purdue Pharma Inc. to 2/15/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint24 is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 2/15/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint25 is granted pursuant to Local Rule CV-12 for The Purdue Frederick Company to 2/15/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint27 is granted pursuant to Local Rule CV-12 for Purdue Pharma Inc. to 3/2/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint28 is granted pursuant to Local Rule CV-12 for Purdue Pharma L.P. to 3/2/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed Second Application for Extension of Time to Answer Complaint29 is granted pursuant to Local Rule CV-12 for The Purdue Frederick Company to 3/2/2018. 15 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint32 is granted pursuant to Local Rule CV-12 for Janssen Pharmaceuticals, Inc. to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint33 is granted pursuant to Local Rule CV-12 for Janssen Pharmaceutica Inc to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint34 is granted pursuant to Local Rule CV-12 for Ortho-McNeil-Janssen Pharmaceuticals, Inc. to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| Defendant's Unopposed First Application for Extension of Time to Answer Complaint35 is granted pursuant to Local Rule CV-12 for Johnson & Johnson to 2/12/2018. 30 Days Granted for Deadline Extension.( mll, ) [Transferred from txed on 1/23/2018.] | ||
| 30 | 30
NOTICE of Attorney Appearance by Stephen Edward McConnico on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| 31 | 31
CORPORATE DISCLOSURE STATEMENT filed by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc. (McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| 32 | 32
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| 33 | 33
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Janssen Pharmaceutica Inc.( McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| 34 | 34
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Ortho-McNeil-Janssen Pharmaceuticals, Inc..( McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| 35 | 35
Defendant's Unopposed First Application for Extension of Time to Answer Complaint re Johnson & Johnson.( McConnico, Stephen) [Transferred from txed on 1/23/2018.]
|
|
| Thursday, January 18, 2018 | ||
| 36 | 36
AFFIDAVIT OF PROOF OF SERVICE by County of Smith. The following Defendants have been served by cert mail: PURDUE PHARMA, L.P. 12/26/17; PURDUE PHARMA, INC. 12/26/17; THE PURDUE FREDERICK COMPANY 12/26/17; JOHNSON & JOHNSON 12/28/17; JANSSEN PHARMACEUTICALS, INC.; ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. n/k/a JANSSEN PHARMACEUTICALS, INC.; and JANSSEN PHARMACEUTICA, INC. n/k/a JANSSEN PHARMACEUTICALS, INC. 12/22/17; ENDO HEALTH SOLUTIONS INC. 12/27/17; ENDO PHARMACEUTICALS, INC. 12/22/17; ABBVIE INC. 12/27/17; KNOLL PHARMACEUTICALCOMPANY 12/29/17; ALLERGAN FINANCE LLC 12/26/17; WATSON LABORATORIES, INC. 12/22/17; ACTAVIS LLC 12/27/17; ACTAVIS PHARMA, INC. 12/22/17; MCKESSONCORPORATION 12/28/17; CARDINAL HEALTH, INC. 12/27/17; AMERISOURCEBERGEN CORPORATION 12/26/17. (mll, ) [Transferred from txed on 1/23/2018.]
|
|
| Friday, January 19, 2018 | ||
| Interdistrict transfer to the Northern District of Ohio (MDL 2804). In Re: National Prescription Opiate Litigation. (mll, ) [Transferred from txed on 1/23/2018.] | ||
| 37 | 37
CONDITIONAL TRANSFER ORDER (CTO 4). This action is transferred to the Northern District of Ohio, and assigned to the docket of the Honorable Dan A. Polster. (MDL 2804) (mll, ) [Transferred from txed on 1/23/2018.]
|
|
| Tuesday, January 23, 2018 | ||
| 38 | 38
CASE TRANSFERRED IN from District of Texas Eastern. Case number 6:17-cv-00699. Original file, certified copy of transfer order and docket sheet received.
|
|